Article info

Download PDFPDF
Cost-effectiveness
Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention

Authors

  1. Correspondence to : Dr Joseph Yeboah, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem NC 27157, USA; jyeboah{at}wakehealth.edu
View Full Text

Citation

Yeboah J
Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention

Publication history

  • First published September 2, 2015.
Online issue publication 
November 24, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.